Literature DB >> 20351569

The thyroid and the gut.

Ellen C Ebert1.   

Abstract

Thyroid disease is common, and its effects on the gastrointestinal system are protean, affecting most hollow organs. Hashimoto disease, the most common cause of hypothyroidism, may be associated with an esophageal motility disorder presenting as dysphagia or heartburn. Dyspepsia, nausea, or vomiting may be due to delayed gastric emptying. Abdominal discomfort, flatulence, and bloating occur in those with bacterial overgrowth and improve with antibiotics. Reduced acid production may be due to autoimmune gastritis or low gastrin levels. Constipation may result from diminished motility, leading to an ileus, megacolon, or rarely pseudoobstruction. Ascites in myxedema is characterized by a high protein concentration. Graves' disease accounts for 60% to 80% of thyrotoxicosis. Hyperthyroidism is accompanied by normal gastric emptying with low acid production, partly due to an autoimmune gastritis with hypergastrinemia. Transit time from mouth to cecum is accelerated, resulting in diarrhea. Steatorrhea is due to hyperphagia and stimulation of the adrenergic system. Diarrhea in medullary carcinoma of the thyroid (MCT) may be due to elevated calcitonin, prostaglandins, or 5-hydroxyindoleacetic acid. Ileal or colonic function may be abnormal. The esophagus may be compressed by benign processes, but more often by malignancies. MRI and CT scans are the best diagnostic modalities. The gastrointestinal manifestations of thyroid disease are generally due to reduced motility in hypothyroidism, increased motility in hyperthyroidism, autoimmune gastritis, or esophageal compression by a thyroid process. Symptoms usually resolve with treatment of the thyroid disease.

Entities:  

Mesh:

Year:  2010        PMID: 20351569     DOI: 10.1097/MCG.0b013e3181d6bc3e

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  31 in total

Review 1.  Occult primary medullary thyroid carcinoma presenting with pituitary and parotid metastases: case report and review of the literature.

Authors:  Andrea Conway; Andres Wiernik; Ajay Rawal; Cornelius Lam; Hector Mesa
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

2.  The PNEI holistic approach in coloproctology.

Authors:  M Pescatori; V Podzemny; L C Pescatori; M P Dore; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-03-29       Impact factor: 3.781

Review 3.  Thyroid hormone regulation of adult intestinal stem cells: Implications on intestinal development and homeostasis.

Authors:  Guihong Sun; Julia Roediger; Yun-Bo Shi
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

4.  Coincidental Killian-Jamieson Diverticulum During Thyroid Surgery: A Rare Cause of Dysphagia.

Authors:  Güleser Saylam; Kemal Keseroğlu; Ömer Bayır; Emel Çadallı Tatar; Mehmet Hakan Korkmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-12-01

Review 5.  Update on chronic diarrhea: a run-through for the clinician.

Authors:  Davinder K Sandhu; Christina Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2012-10

6.  Thyrotoxic vomiting: a case report and possible mechanisms.

Authors:  Soyeon Shim; Han Seung Ryu; Hyo Jung Oh; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

7.  Reduction of gastrointestinal motility by unilateral thyroparathyroidectomy plus subdiaphragmatic vagotomy in rats.

Authors:  Jun Ho Lee; Oh Deog Kwon; Seon Ho Ahn; Keun Han Choi; Ji Hye Park; Seoul Lee; Bong Kyu Choi; Kyu Yong Jung
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

8.  Evidence of impaired carbohydrate assimilation in euthyroid patients with Hashimoto's thyroiditis.

Authors:  S Heckl; C Reiners; A K Buck; A Schäfer; A Dick; M Scheurlen
Journal:  Eur J Clin Nutr       Date:  2015-10-07       Impact factor: 4.016

9.  DOES GRAVES' DISEASE AFFECT ESOPHAGEAL MOTILITY?

Authors:  Ö Karaman; M İlhan; S Turgut; E Arabaci; H Senturk; E Taşan
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

10.  Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.

Authors:  Elizabeth Fox; Brigitte C Widemann; Meredith K Chuk; Leigh Marcus; Alberta Aikin; Patricia O Whitcomb; Maria J Merino; Maya Lodish; Eva Dombi; Seth M Steinberg; Samuel A Wells; Frank M Balis
Journal:  Clin Cancer Res       Date:  2013-06-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.